Reyon Pharmaceutical Co. Ltd. (102460)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
9,920. 00
+20
+0.202%
₩
221.93B Market Cap
- P/E Ratio
600% Div Yield
66,256 Volume
- Eps
₩ 9,900
Previous Close Want to track 102460 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | 133.53 |
| | | - | 135.61 |
| | | - | 241.18 |
| | | - | 23.15 |
| | | - | 222.45 |
| | | - | 190.2 |
| | | - | 227.02 |
| | | - | 157.37 |
| | | - | 189.64 |
| | | - | 157.95 |
| | | - | 172.8 |
| | | - | 205.23 |
| | | - | 218.38 |
| | | - | 94.98 |
| | | - | 141.66 |
102460 Earnings Reports FAQ
What is the earnings per share (EPS) for 102460?
EPS data for 102460 is currently not available, as Reyon Pharmaceutical Co. Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 3 years, the earnings growth rate has been approximately -1.95%, reflecting the 102460's performance and KRX SM market conditions.
When is the next earnings release date?
Reyon Pharmaceutical Co. Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Reyon Pharmaceutical Co. Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 102460 at this time, as Reyon Pharmaceutical Co. Ltd has no recent EPS data to calculate it.
